The Heartland Study is a prospective, observational study that will enroll up to 2,600 pregnant participants across the Heartland States in the U.S.. The objective of the Heartland Study is to address major knowledge gaps concerning the health effects of herbicides on maternal and infant health. The study is being conducted to evaluate the associations between environmental exposures to herbicides during and after pregnancy and reproductive health outcomes. The study is measuring multiple biomarkers of herbicide exposure among pregnant Midwesterners and their partners to evaluate associations with pregnancy and childbirth outcomes, epigenetic biomarkers of exposure, and child development.
During Phase 1 of the Study, newly pregnant mothers will be enrolled less than or equal to 20 weeks + 6 days gestation and followed through to the end of pregnancy. Prenatal urine and buccal (cheek) samples will be collected to measure urinary herbicide exposure levels and to identify herbicide induced epigenetic biomarkers. Pregnancy outcomes and fetal health will be documented and analyzed to further investigate potential effects of fetal exposure. Indirect measures such as food and beverage consumption, workplace and household related chemical exposures, substance use, residential proximity to agricultural fields, and socioeconomic factors will be captured from questionnaires.
Study Type
OBSERVATIONAL
Enrollment
2,600
Indiana University Medical Center
Indianapolis, Indiana, United States
RECRUITINGUniversity of Iowa Health Care
Iowa City, Iowa, United States
RECRUITINGGundersen Health
La Crosse, Wisconsin, United States
COMPLETEDMarshfield Clinic
Marshfield, Wisconsin, United States
RECRUITINGPregnancy loss
Number of participants who experience a pregnancy loss
Time frame: Enrollment to birth
Preterm birth
Number of births that occur between gestational age 20 +0 and 36 +6
Time frame: Enrollment to gestational age 36 +6
Hypertensive disorders of pregnancy
Number of participants diagnosed with a hypertensive disorder of pregnancy
Time frame: Enrollment to up to twelve weeks after delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.